Best Penny Stocks To Buy In 2023
mintmarkDive into the exciting world of high-potential, low-priced stocks with Stocklytics' Best Penny Stocks selection. Stocklytics combs through the market's volatility to unearth stocks with immense growth potential. These picks aren't just about affordability; they're backed by robust fundamentals, promising narratives, and compelling trajectories. Whether you're a speculative investor or seeking aggressive growth opportunities, Stocklytics' list presents intriguing options that could be the catalyst for substantial returns in your investment journey.
| name | Price | $ Change | % Change | Market Cap | arrow_downwardScore language | Tags | Volume | Avg. Volume | Technicals | Dividend Y | ROI 1Y | Last 7 Days | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
XERSXeris Pharmaceuticals | $3.47 | $0.10 | arrow_drop_up3.12% | $517.02M | Penny Stock | 6.68M | 3.48 | Neutralremove | - | 92.24% | AI Analysis | |||||
BOSCBOS Better On-Line Solutions | $2.95 | $0.01 | arrow_drop_up0.54% | $17.20M | High Value | 4.62K | 2.96 | Sellkeyboard_arrow_down | - | 7.49% | AI Analysis | |||||
BTCYBiotricity | $0.26 | -$0.04 | arrow_drop_down14.06% | $7.68M | Penny Stock | 0.00 | 62.37K | Neutralremove | - | -68.67% | AI Analysis | |||||
ALTOAlto Ingredients | $1.30 | $0.10 | arrow_drop_up8.26% | $99.43M | Penny Stock | 3.24M | 1.29 | Neutralremove | - | -37.79% | AI Analysis | |||||
UTRSMinerva Surgical | $0.01 | $0.00 | 0.00% | $106.54K | High Growth | 0.00 | 0.00 | Buykeyboard_arrow_up | - | -99.53% | AI Analysis | |||||
NVVENuvve Holding | $3.31 | $0.01 | arrow_drop_up0.30% | $2.16M | High Growth | 11.08K | 3.31 | Neutralremove | - | -95.52% | AI Analysis | |||||
CMRXChimerix | $0.99 | $0.04 | arrow_drop_up4.89% | $88.74M | Penny Stock | 920.40K | 1.03 | Neutralremove | - | 4.21% | AI Analysis | |||||
DHXDHI Group | $1.83 | $0.03 | arrow_drop_up1.63% | $88.57M | Penny Stock | 101.15K | 1.84 | Neutralremove | - | -10.48% | AI Analysis | |||||
 AMCAMC Entertainment Holdings | $4.27 | -$0.03 | arrow_drop_down0.69% | $1.60B | Penny Stock | 12.99M | 4.22 | Neutralremove | - | -50.97% | AI Analysis | |||||
QLGNQualigen Therapeutics | $4.77 | $0.31 | arrow_drop_up6.84% | $3.51M | Penny Stock | 103.58K | 4.54 | Sellkeyboard_arrow_down | - | -85.75% | AI Analysis | |||||
ADTHAdTheorent Holding Company | $3.20 | $0.00 | 0.00% | $294.06M | High Growth | 0.00 | 555.26K | Neutralremove | - | 160.16% | AI Analysis | |||||
IDEXIdeanomics | $0.10 | $0.06 | 0.00% | $2.00M | Penny Stock | 395.00 | 6.88K | Neutralremove | - | -94.97% | AI Analysis | |||||
CRONCronos Group | $2.00 | -$0.06 | arrow_drop_down2.91% | $764.56M | Penny Stock | 1.03M | 2.00 | Neutralremove | - | 1.52% | AI Analysis | |||||
SBSafe Bulkers | $4.34 | -$0.05 | arrow_drop_down1.13% | $463.38M | Penny Stock | 481.50K | 4.34 | Neutralremove | 4.56% | 36.05% | AI Analysis | |||||
BKYIBio-key International | $1.16 | $0.00 | 0.00% | $3.60M | Penny Stock | 117.71K | 1.16 | Neutralremove | - | -65.35% | AI Analysis | |||||
TACTTransAct Technologies | $4.23 | -$0.16 | arrow_drop_down3.77% | $42.29M | Penny Stock | 127.62K | 4.08 | Neutralremove | - | -31.33% | AI Analysis | |||||
OCUPOcuphire Pharma | $1.17 | -$0.16 | arrow_drop_down12.40% | $31.73M | Penny Stock | 676.71K | 1.17 | Neutralremove | - | -59.37% | AI Analysis | |||||
BLUEBluebird Bio | $0.40 | $0.02 | arrow_drop_up7.43% | $78.67M | Penny Stock | 5.97M | 0.40 | Neutralremove | - | -86.63% | AI Analysis | |||||
AMPEAmpio Pharmaceuticals | $0.00 | $0.00 | 0.00% | $2,497.00 | High Value | 416.00 | 568.00 | Neutralremove | - | -99.92% | AI Analysis | |||||
XXII22nd Century Group | $0.11 | $0.00 | arrow_drop_up0.59% | $5.48M | Penny Stock | 4.91M | 0.11 | Neutralremove | - | -98.18% | AI Analysis |
Showing 241-260 of 322
Results per page:
About Best Penny Stocks To Buy In 2023
Dive into the exciting world of high-potential, low-priced stocks with Stocklytics' Best Penny Stocks selection. Stocklytics combs through the market's volatility to unearth stocks with immense growth potential. These picks aren't just about affordability; they're backed by robust fundamentals, promising narratives, and compelling trajectories. Whether you're a speculative investor or seeking aggressive growth opportunities, Stocklytics' list presents intriguing options that could be the catalyst for substantial returns in your investment journey.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools